Thondawada, Mahesh <br/><br/>
An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes.  [electronic resource] 

 -  Drug development and industrial pharmacy  Jul 2018 
 - 1120-1129 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1520-5762 
<br/><br/><label>Standard No.: </label>10.1080/03639045.2018.1438460  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--chemistry<br/>CD4 Antigens--chemistry<br/>Cell Line, Tumor<br/>Delayed-Action Preparations--chemistry<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Dipeptidyl Peptidase 4--metabolism<br/>Dipeptidyl-Peptidase IV Inhibitors--chemistry<br/>Drug Carriers--chemistry<br/>Drug Delivery Systems--methods<br/>Hypoglycemic Agents--chemistry<br/>Lactic Acid--chemistry<br/>Nanoparticles--chemistry<br/>Particle Size<br/>Polyglycolic Acid--chemistry<br/>Polylactic Acid-Polyglycolic Acid Copolymer<br/>Polymers--chemistry<br/>Rats